Pharmacy Daily | TGA set for labelling review

THE Therapeutic Goods Administration has announced a review of the labelling and packaging regulatory framework covering prescription, OTC and complementary medicines. A consultation paper is set to be released in October, with the move following the recent review to improve the transparency of the TGA which contained a number of recommendations about labelling. Submissions to the review included a number of comments about the TGA’s role in regulating and monitoring medicine labelling, including “notable concerns about the placement of pharmacy labels over manufacturers’ labels, thereby covering mandatory information including important dosage and active ingredient information”. Other issues raised included calls for a consistent approach by the TGA to the approval of product names “to ensure certainty for industry and safety for consumers”. It’s also been suggested that details of non-active ingredients also be included on therapeutic goods labels to help users make “informed decisions”.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 11 Aug 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Aug 11